Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sinopharm Tech Holdings's total inventories for the quarter that ended in Dec. 2025 was HK$3.52 Mil. Sinopharm Tech Holdings's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was HK$8.50 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Sinopharm Tech Holdings's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was HK$-0.28.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Sinopharm Tech Holdings's Days Inventory for the
six
months ended in Dec. 2025 was 72.31.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sinopharm Tech Holdings's Inventory Turnover for the quarter that ended in Dec. 2025 was 2.52.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sinopharm Tech Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.32.
Sinopharm Tech Holdings (HKSE:08156) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Sinopharm Tech Holdings's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sinopharm Tech Holdings's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Sinopharm Tech Holdings Total Inventories Related Terms
Sinopharm Tech Holdings Total Inventories Historical Data
* Premium members only.
The historical data trend for Sinopharm Tech Holdings's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Tech Holdings Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of HK$3.52 Mil mean?
Sinopharm Tech Holdings (HKSE:08156) has a Total Inventories of HK$3.52 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Sinopharm Tech Holdings and its competitors.
Is Sinopharm Tech Holdings' Total Inventories too high?
Sinopharm Tech Holdings' current Total Inventories is HK$3.52 Mil. Overall, Sinopharm Tech Holdings has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Tech Holdings' Total Inventories compare to QH and SHOP?
Sinopharm Tech Holdings' Total Inventories of HK$3.52 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Software company?
A good Total Inventories depends on the Software industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Sinopharm Tech Holdings and its competitors. Sinopharm Tech Holdings's current Total Inventories is HK$3.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Tech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Tech Holdings (HKSE:08156) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.16 — trading 160% above its estimated fair value. The current Total Inventories is HK$3.52 Mil. Sinopharm Tech Holdings' overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Sinopharm Tech Holdings (HKSE:08156), the current Total Inventories is HK$3.52 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Tech Holdings (HKSE:08156) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Tech Holdings stock appears to be overvalued.
The current stock price of HK$0.16 is trading 160% above its estimated GF Value™ of HK$0.06.
GuruFocus considers Sinopharm Tech Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:08156:
Total Inventories: HK$3.52 Mil
GF Value™: HK$0.06 vs. price of HK$0.16 (160% above fair value)
No single metric tells the full story. See the HKSE:08156 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinopharm Tech Holdings Ltd is an investment holding company operating through three segments: Internet Plus services, Supply Chain services, and Manufacturing and distribution of personal protective equipment. The company generates the majority of its revenue from the Supply Chain services segment, which includes supply chain management, data analysis, and trading of medical and related products. Geographically, it operates in Hong Kong and the People's Republic of China (PRC), with the majority of its revenue coming from the PRC.
27GF Score
Get the complete analysis for HKSE:08156
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08156 has been successfully added to your 
